Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and sr141716

quinoxalines has been researched along with sr141716 in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (73.68)29.6817
2010's5 (26.32)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gitlin, JM; Mitchell, JA; Stanford, SJ1
Camarelles Guillem, F1
Corelli, RL; Hudmon, KS1
Frishman, WH1
Pipe, AL; Quinlan, B; Reid, RD; Riley, DL1
Anthenelli, RM1
Cahill, K; Lancaster, T; Stead, L1
Wonnacott, S1
Carrozzi, L; Pistelli, F; Viegi, G1
Di, S; Franco, A; Maxson, MM; Tasker, JG1
Aveyard, P; Hajek, P; Inglis, J; Parsons, AC; Shraim, M1
Kovacs, FE; Szabo, B; Urbanski, MJ1
Baki, A; Fischer, J; Keseru, GM; Kiss, R; Molnár, L; Páyer-Lengyel, D; Szabó, G; Szikra, J; Vukics, K1
Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T1
Bhat, A; Crain, D1
Henriksen, EJ; Jacob, S; Lindborg, KA; Teachey, MK1
Agboola, S; Coleman, T; Leonardi-Bee, J; McEwen, A; McNeill, A; Taylor, M1
Kramar, C; Laviolette, SR; Loureiro, M; Renard, J; Rosen, LG1
Busquets-Garcia, A; Galera-López, L; Gomis-González, M; Maldonado, R; Martín-García, E; Ozaita, A; Puighermanal, E; Salgado-Mendialdúa, V1

Reviews

7 review(s) available for quinoxalines and sr141716

ArticleYear
Pharmacologic interventions for smoking cessation.
    Critical care nursing clinics of North America, 2006, Volume: 18, Issue:1

    Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline

2006
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
    Preventive cardiology, 2007,Spring, Volume: 10, Issue:2 Suppl 1

    Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline

2007
Smoking cessation: lessons learned from clinical trial evidence.
    Current opinion in cardiology, 2007, Volume: 22, Issue:4

    Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline

2007
An update on therapeutics for tobacco dependence.
    Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:1

    Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline

2008
Pharmacotherapy for smoking cessation.
    Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline

2008
Interventions for preventing weight gain after smoking cessation.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Antidepressive Agents; Benzazepines; Exercise; Female; Humans; Male; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Varenicline; Weight Gain

2009
Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
    Health technology assessment (Winchester, England), 2010, Volume: 14, Issue:49

    Topics: Benzazepines; Cost-Benefit Analysis; Evidence-Based Medicine; Health Promotion; Humans; Nicotinic Agonists; Piperidines; Public Health; Pyrazoles; Qualitative Research; Quinoxalines; Rimonabant; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Marketing; State Medicine; Treatment Failure; United Kingdom; Varenicline

2010

Other Studies

12 other study(ies) available for quinoxalines and sr141716

ArticleYear
Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.
    British journal of pharmacology, 2001, Volume: 133, Issue:6

    Topics: Adenine; Adenosine; Adenosine Triphosphate; Animals; Arachidonic Acids; Capsaicin; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Histamine; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Piperidines; Polyunsaturated Alkamides; Potassium Chloride; Pyrazoles; Pyrilamine; Quinoxalines; Rats; Rats, Wistar; Rimonabant; Signal Transduction; Stereoisomerism; Theophylline; Vasodilation

2001
[Medication for ending tobacco dependency. Current state].
    Atencion primaria, 2005, Jun-30, Volume: 36, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline

2005
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
    Nature clinical practice. Cardiovascular medicine, 2007, Volume: 4, Issue:9

    Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007
Smoking cessation 2008.
    IDrugs : the investigational drugs journal, 2008, Volume: 11, Issue:4

    Topics: Benzazepines; Cannabinoid Receptor Antagonists; Drug Prescriptions; Humans; Marketing of Health Services; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Vaccines; Varenicline

2008
Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jan-14, Volume: 29, Issue:2

    Topics: Animals; Arginine; Cannabinoid Receptor Modulators; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Dronabinol; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glucocorticoids; Glutamic Acid; GTP-Binding Proteins; Guanosine Diphosphate; Hypothalamus; In Vitro Techniques; Male; Neurons; Nitric Oxide; Nitric Oxide Donors; Patch-Clamp Techniques; Penicillamine; Piperidines; Pyrans; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Rimonabant; Signal Transduction; Synapses; Synaptic Transmission; Thionucleotides; Valine

2009
Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling.
    Synapse (New York, N.Y.), 2009, Volume: 63, Issue:8

    Topics: Aniline Compounds; Animals; Animals, Newborn; Arachidonic Acids; Benzamides; Bicuculline; Biophysics; Calcium; Calcium Signaling; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Carbamates; Cerebellum; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fluoresceins; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycerides; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Lactones; Mice; Muscimol; Orlistat; Patch-Clamp Techniques; Piperidines; Purkinje Cells; Pyrazoles; Quinoxalines; Rimonabant; Signal Transduction; Synapses; Valine

2009
Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2009, Jul-01, Volume: 19, Issue:13

    Topics: Animals; Binding Sites; Computer Simulation; Piperidines; Pyrazoles; Quinoxalines; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Structure-Activity Relationship

2009
[Current and future medical drugs for smoking cessation].
    Laryngo- rhino- otologie, 2009, Volume: 88, Issue:6

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline

2009
Current treatment options in smoking cessation.
    Hospital practice (1995), 2010, Volume: 38, Issue:1

    Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline

2010
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle.
    Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:8

    Topics: Animals; Biological Transport; Female; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Muscle, Skeletal; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Rimonabant

2010
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
    Biological psychiatry, 2016, 08-01, Volume: 80, Issue:3

    Topics: Animals; Avoidance Learning; Benzoxazines; Cognition; Conditioning, Psychological; Dizocilpine Maleate; Emotions; Hippocampus; Male; Memory; Microinjections; Morpholines; Naphthalenes; Neurons; Nucleus Accumbens; Piperidines; Pyrazoles; Quinoxalines; Rats; Receptor, Cannabinoid, CB1; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Reward; Rimonabant; Social Behavior

2016
Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:5

    Topics: Animals; Anisomycin; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Hippocampus; Isoenzymes; Male; Memory, Short-Term; Mice; Microinjections; Neurogranin; Phenols; Phosphorylation; Piperidines; Protein Kinase C; Quinoxalines; Rimonabant; Signal Transduction; Sirolimus

2018